“The current study concludes that cannabis acts as a new competitor in drug markets.”
Pharma stocks drop 1.5 to 2 percent within ten days of a state legalizing cannabis. Full federal legalization would cut conventional drug sales by almost 11 percent, by the authors’ math. Branded drugmakers take the biggest hit. Pharma has billions of reasons to keep weed illegal.